Long-term Safety and Effectiveness of Growth Hormone With GHD, TS, CRF, SGA , ISS and PWS in Children
Long-term Safety and Effectiveness of Growth Hormone With GHD, TS, CRF, SGA , ISS and PWS in Children
The purpose of this study is to evaluate the long-term safety and effectiveness of growth
 hormone (Eutropin Inj./Eutropin plus Inj.) treatment with GHD (Growth Hormone Deficiency), TS
 (Turner Syndrome),CRF (Chronic Renal Failure), SGA (Small for Gestational Age), and ISS
 (Idiopathic Short Stature).
Inclusion Criteria:

 -  short stature children aged 2 years or more

 -  children with GHD,TS, CRF, SGA or ISS

 -  written informed consent from the person, person's parent or legal guardian